On the relationship between drug and carrier deposition from dry powder inhalers in vitro

[1]  P. Hagedoorn,et al.  Inhalation characteristics and their effects on in vitro drug delivery from dry powder inhalers part 2: effect of peak flow rate (pifr) and inspiration time on the in vitro drug release from three different types of commercial dry powder inhalers , 1996 .

[2]  R. Niven,et al.  The influence of formulation on emission, deaggregation and deposition of dry powders for inhalation , 1996 .

[3]  R. Schultz,et al.  Effect of inhalation flow rate on the dosing characteristics of dry powder inhaler (DPI) and metered dose inhaler (MDI) products. , 1996, Journal of aerosol medicine : the official journal of the International Society for Aerosols in Medicine.

[4]  Peter R. Byron,et al.  Dose emissions from marketed dry powder inhalers , 1995 .

[5]  A. Clark.  The use of laser diffraction for the evaluation of the aerosol clouds generated by medical nebulizers , 1995 .

[6]  P. Ventura,et al.  A comparison of the lung deposition of salbutamol inhaled from a new dry powder inhaler, at two inhaled flow rates , 1994 .

[7]  A. Hickey,et al.  FACTORS INFLUENCING THE DISPERSION OF DRY POWDERS AS AEROSOLS , 1993 .

[8]  P. Zanen,et al.  The effect of inhalation flow on the performance of a dry powder inhalation system. , 1992, European journal of drug metabolism and pharmacokinetics.

[9]  S. Clarke,et al.  Terbutaline sulphate Turbuhaler: effect of inhaled flow rate on drug deposition and efficacy , 1991 .

[10]  D. Pavia,et al.  Effect of aerosol particle size on bronchodilatation with nebulised terbutaline in asthmatic subjects. , 1986, Thorax.

[11]  J. Staniforth,et al.  Interparticle forces in binary and ternary ordered powder mixes , 1982, The Journal of pharmacy and pharmacology.

[12]  J. Carstensen,et al.  Pharmaceutics of solids and solid dosage forms , 1977 .